ILLUMICELL
LIVE

Serial Number

50146703

Owner

Testasy, Inc

Attorney

Veda Lejardi Cruz

First Use Date

Apr 11, 2025

Filing Date

Oct 6, 2026

Add to watchlist:

No watchlists yet
View on USPTO

ILLUMICELL Trademark

Serial Number: 50146703

ILLUMICELL is a trademark filed by Testasy, Inc on October 6, 2026. The trademark is classified under Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Testasy, Inc

127 Western Ave
Allston, MA 02134

Entity Type: 03

Trademark Details

Filing Date

October 6, 2026

Registration Date

Not Registered

First Use Anywhere

April 11, 2025

First Use in Commerce

April 11, 2025

Goods & Services

Scientific and technological services, namely, scientific research, testing and analysis in the field of cellular biology, reproductive health, immunology, oncology and autoimmune disease; Scientific and technological services, namely, research and design in the field of cellular biology, reproductive health, immunology, oncology and autoimmune disease; Providing medical and scientific research information; Medical and scientific research in the field of medical diagnostics; Research and development of technology in the field of medical diagnostics; Scientific and technological services, namely, analysis in the field of biological samples and cellular activity; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for analyzing biological samples, cellular images and cellular data; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for analysis of biological samples and cellular data for research and clinical purposes

Medical specimen collection devices in the nature of specimen collection cups for the collection of semen; Medical diagnostic apparatus for testing semen; Medical diagnostic apparatus for testing biological samples and bodily fluids

Medical testing for diagnostic and treatment purposes; Medical testing for diagnostic or treatment purposes in the field of reproductive health, male fertility, immunology, oncology and autoimmune disease; Medical diagnostic testing, monitoring and reporting services; Medical testing for diagnostic or treatment purposes in the field of semen analysis

Filing History

APPLICATION FILING RECEIPT MAILED
Oct 6, 2026 MAFR
NEW APPLICATION ENTERED
Oct 6, 2026 NWAP